Clinical Trial Update: A Trial of Isoniazid for the Reversion of Interferon Gamma ELISPOT in Tuberculosis (TB) Case Contacts [NA]

View source ↗

Summary

A completed clinical trial evaluating whether isoniazid can reverse IFN-gamma ELISPOT responses in tuberculosis case contacts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• ISONIAZID (ISONIAZID)

Snippet

Sponsor: Medical Research Council Unit, The Gambia | Conditions: Tuberculosis | NA | Status: COMPLETED